SINT (Sintx Technologies) Net Profit

Corporate emblem and logo of Sintx Technologies (SINT)

Sintx Technologies (SINT) total profit demonstrates resilience driven by the production of ultra-high-strength ceramics for aviation, defense, and medicine. Stability of supplies to clinics is maintained through strict control of sterile transportation. Meanwhile, patents curb competition, although major customers limit the growth of wholesale prices. The value of -0.02 reflects the baseline level of the metric, helping to assess the balance between business reliability and asset yield.

SINT: Sintx Technologies Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for sintx.com (SINT)

- current quotes and average value forecast:
Market Chart Sintx Technologies, Inc.|SINT - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization SINT|SINT - Total Company Value
- book capitalization data:
Net Assets per Single Share Sintx Technologies|SINT - Book Capitalization|Market Capitalization to Book Value sintx.com|SINT - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Sintx Technologies|SINT - Long-Term Debt to Capital|Current Liabilities to Capital Sintx Technologies, Inc.|SINT - Company Aggregate Debts|Debt to Book Value Ratio SINT|SINT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Sintx Technologies|Quick Liquidity Indicator sintx.com
- earnings and valuation multiples information:
SINT - Net Profit
Fundamental valuation:SINTX Technologies
Product sample of Sintx Technologies

Net income reflects the final financial result after deducting all operating expenses and taxes, serving as a key indicator of real business efficiency. By analyzing the company's profit margins, an investor can see how the high margins of Sintx Technologies (SINT) unique ceramic patents offset the slow scaling of physical capacities, ensuring capitalization stability even with limited production volumes.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit CARL (Carlsmed Inc)|Net Profit rxsight.com RXST|CLPT - Company Net Income|STXS: Company Net Income|STIM (NeuroStar) - Net Income|Sight Sciences Inc - Final Profit|OBIO (Orchestra BioMed) - Net Profit|Company Net Income Anika ANIK|Company Net Income InspireMD (NSPR)|zhjmedical.com (ZJYL) - Annual Net Income|Vivani Medical - Net Income|Net Profit Xtant Medical Holdings, Inc. XTNT|NeuroOne Medical Technologies - Net Profit|Net Financial Result Modular Medical MODD|Myomo (MYO) - Company Net Income|Profit After Tax COCH (Envoy Medical Inc.)|Company Net Income Vivos Therapeutics, Inc|Net Income enVVeno Corp (NVNO)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOLASE, Inc. (BIOL) - Company Net Income|DYNT - Net Financial Result|FNA (Paragon 28 Inc.) - Net Profit|INVO Bio (INVO) - Net Financial Result